Abstract
128 Increased dosage of elapegademase-lvlr improved metabolic and immunologic function in a patient with late-onset adenosine deaminase deficiency and neutralizing anti-drug antibodies
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
